sufficiently old [12:< 18 years). The racial distribution of patients receiving Rhinocort Aqua Nasal Spray was 93% white, 3% black and 4% other. Table 1 describes adverse reactions occurring at an incidence of 2% or greater and more commonly among Rhinocort Aqua Nasal Spray-treated patients than in placebo-treated patients in controlled clinical trials. Table 1. Adverse Reactions occurring at an incidence 2% and more commonly than placebo in the Rhinocort Aqua Nasal Spray group in patients 6 years and older Adverse Event Rhinocort Aqua Nasal Spray Placebo Vehicle Epistaxis 8% 5% Pharyngitis 4% 3% Bronchospasm 2% 1% Coughing 2%] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Manufacturer AstraZeneca Drug Class Nasal steroids Related Drugs nasal steroids fluticasone nasal , Flonase , triamcinolone nasal , budesonide nasal , Nasonex Allergic Rhinitis prednisone , Zyrtec , promethazine , fluticasone nasal , loratadine , cetirizine , Flonase , triamcinolone , montelukast , Claritin , Singulair , diphenhydramine , Benadryl , fexofenadine , budesonide nasal , Medrol , dexamethasone , Nasonex , methylprednisolone , azelastine nasal , mometasone nasal , levocetirizine , Allegra , More... Rhinocort Aqua Rating 4 User Reviews 8.0 /10 4 User Reviews 8.0 Rate it! charges
best Rhinocort Aqua along with your
EmoticonEmoticon